ESR1 and breast cancer: Triple-negative breast cancer (TNBC) represents 15–20% of all breast cancers (BCs); it is characterized by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and the absence of HER2 gene amplification1,2.